about
Avian influenza and oseltamivir; a retrospective viewPolymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle.Neuroinvasion by human herpesvirus type 7 in a case of exanthem subitum with severe neurologic manifestations.Toxoplasmosis after renal transplantation: implications of a missed diagnosisSomatic hypotheses of war syndromes.Evaluating neuropsychological impairment in chronic fatigue syndrome.The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model.The pathogenesis of febrile seizures: is there a role for specific infections?Activation of measles virus from silently infected human lymphocytes.Prognosis in chronic fatigue syndrome: a prospective study on the natural course.Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy.Human enterovirus surveillance in the Slovak Republic from 2001 to 2011.Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells.Study on microbial persistence in end-stage idiopathic dilated cardiomyopathy.Severe human psittacosis requiring artificial ventilation: case report and review.Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule.Epidemiological survey of neonatal non-polio enterovirus infection in the Netherlands.Lymphocyte-mediated cytotoxicity to autologous cells infected with measles virus. II. Specificity of the cytotoxic reaction and characterization of the effector cells involved.Genetic analysis of mengovirus protein 2A: its function in polyprotein processing and virus reproduction.Prolonged enteroviral infection in a patient who developed pericarditis and heart failure after bone marrow transplantation.Yersinia enterocolitica and the chronic fatigue syndrome.Cross-talk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR.Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay.Subacute sclerosing panencephalitis in The Netherlands--1976-1990.Associations between infections and fatigue in a Dutch working population: results of the Maastricht Cohort Study on Fatigue at Work.Psychological job demands as a risk factor for common cold in a Dutch working population.Influenza-associated encephalopathy: no evidence for neuroinvasion by influenza virus nor for reactivation of human herpesvirus 6 or 7.Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65).Chimeric coxsackie B3 virus genomes that express hybrid coxsackievirus-poliovirus 2B proteins: functional dissection of structural domains involved in RNA replication.Coxsackie B1 virus-induced murine myositis: relationship of disease severity to virus dose and antiviral antibody response.Coxsackie B1 virus-induced murine myositis: a correlative study of muscular lesions and serological changes.Prenatal diagnosis and treatment of congenital Toxoplasma gondii infections: an experimental study in rhesus monkeys.Dimensional assessment of chronic fatigue syndrome.Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group.
P50
Q30333021-ad43fc7b-4b30-8944-5d4f-aef33f19c8dbQ33565672-544C26F4-8B50-4F6A-8F86-2BCB83F8324BQ33856806-291A66A1-B99A-4549-832C-77EADE7D36EEQ33885066-87C028D6-1E9A-44CC-9E9E-FA08F0007447Q33908700-A3738683-6D2E-46E1-BFAE-B099643F5665Q34475757-11E1177D-5513-47EE-93D4-6C7D4A07A285Q34484296-85E7C447-37D5-4AF7-B990-DEF99D46EEE8Q34580766-427F9A98-8C1A-41DD-8C7E-50D5010B9E34Q36341927-6911CAE2-3A78-442D-B9BA-E2132E48569EQ36891218-15BA47EF-B340-4FC6-A1D2-4608966989B6Q37241395-C7B5033B-F74E-404B-A75B-2873107AD6EEQ37290708-6411C933-3BE2-4742-B1DD-F39A1BB1E0C9Q37877073-CD43B70B-580C-41F0-8615-CA42484EFB02Q37877627-BF607BA0-30BF-431A-AAA5-41C6BF423E7BQ37887513-72AC6E8A-85C9-4306-9158-382632869347Q38339438-F8D2E079-99C8-4E58-AEB2-5F9C97C23997Q40590627-5D1C3209-9FDC-4CD6-825C-8E26C38B5445Q40728384-168109B1-04EA-439D-B1D2-EB393B81C6F5Q41065910-6B152918-F806-4271-ADE0-0C53241A8317Q41092253-618400BF-56E6-4C1D-850A-8E88684071C3Q41484512-9EE91806-79BF-4F11-AB9E-33EE60A96CF8Q43206630-A665870F-7E71-41D8-B96B-E5B027FB4EFDQ44498215-74B921B8-4836-4E02-AA67-666A83BCD661Q44669188-4F90019F-24F9-4843-BB99-31C933081F97Q44741890-17ED8865-ACE6-4086-9799-71937BE6E1D8Q44974025-FCD2C34E-A6C7-4429-886A-03F9B275B0F6Q45212356-2927A7E3-C4D2-4D13-93E9-02D65BED26BFQ45747650-5ACE3465-10F4-4273-BD60-23F8BB5FEF0BQ45761042-F8A039CF-D796-448F-8035-A9D80751F831Q45778674-DD2F8AD9-98A4-48B7-A3F0-657701C4D7CCQ45783643-3C3E65F0-B373-49A1-AA1D-3EEFE00B5FEEQ48642452-9EFDDE96-4DD7-45BD-BF31-E8594801B4E3Q48839747-5AA956F5-0062-4415-99F0-568010727174Q49173244-A3BA2F9C-FA54-4D0C-8E21-AEE013A911FE
P50
description
researcher of infectious diseases
@en
name
J.M.D. Galama
@en
J.M.D. Galama
@es
Joep Galama
@nl
type
label
J.M.D. Galama
@en
J.M.D. Galama
@es
Joep Galama
@nl
altLabel
J. Galama
@nl
J.M. Galama
@en
J.M.D. Galama
@en
J.M.D. Galama
@nl
Joachim Galama
@en
Joachim Mainze Dodo Galama
@en
Joachim Mainze Dodo Galama
@nl
Joep Galama
@en
prefLabel
J.M.D. Galama
@en
J.M.D. Galama
@es
Joep Galama
@nl
P1006
P214
P1006
P1449
Joep
@nl
P19
P2038
Joep_Galama
P21
P214
P31
P569
1947-01-01T00:00:00Z
P6815
P734
P735
P7859
viaf-178972440